News from Washington: U.S. Supreme Court to Hear Oral Arguments Involving the Food and Drug Administration (FDA) and Mifepristone

“Kentucky Right to Life applauds the U.S. Supreme Court for agreeing to hear the case concerning the lower Court’s restrictions applied to the use mifepristone, the abortion drug that has caused complications for a number of girls and young women.

The dispensing and distribution of these abortion pills are illegal in the Commonwealth, it is a grave concern that Kentucky women and girls are targeted and exploited through heavy marketing, and abortion pills continued to be trafficked illegally across Kentucky”, Addia Wuchner, Director Kentucky Right to Life.

On Wednesday the U.S. Supreme Court announced that it will hear arguments this term regarding the Food and Drug Administration’s decisions in 2016 and 2021 to loosen regulations of the abortion drug mifepristone and whether the challengers have standing to bring their case.

“Wednesday’s decision means the Court will hear about the dangers of the abortion drug combination,” said Carol Tobias, president of National Right to Life. “We hope that the justices will reconsider the approval of this dangerous drug or at least reinstate the long-standing safety protocols.”

“The Biden Administration has promoted unlimited abortion since Day 1,” said Tobias. “Bowing to pressure from pro-abortion groups, this administration has worked to make mifepristone widely available, regardless of the dangers to women and the deaths of preborn children.”